Light AI Appoints John R. Luna as Chief Executive Officer

Executive Summary

• Light AI Inc. appointed John R. Luna as its new Chief Executive Officer, effective January 19, 2026.
• Founder and former CEO Peter Whitehead will transition to the role of Chief Innovation Officer to continue leading medical diagnostic product development.
• The company disclosed cash and investments of approximately CDN$6.5 million as of December 31, 2025 and expects sufficient capital to fund regulatory and commercialization initiatives through at least Q3 2026; a fractional CFO will replace departing CFO George Reznik.

Key Details

• New CEO: John R. Luna – 30+ years experience in healthcare technology, AI‑enabled medical devices, FDA 510(k) and De Novo pathways, and global commercialization.
• Former CEO Transition: Peter Whitehead moves to Chief Innovation Officer, focusing on medical diagnostic offering expansion and intellectual property development.
• Financial Position: Cash & investments ≈ CDN$6.5 million (as of Dec 31 2025); runway expected to cover regulatory/commercialization activities beyond Q3 2026.
• Expense Outlook: Anticipated reduction in R&D and other operating expenses; increased spending on regulatory and commercialization initiatives.
• CFO Change: George Reznik departing; a part‑time fractional CFO will be engaged to preserve financial runway.
• Board Statement: Chair Steven Semmelmayer highlighted Luna’s expertise in FDA pathways, AI medical platforms, and capital‑efficient growth as key to accelerating market opportunity.

Notable Quotes

“Light AI represents the future of diagnostics in healthcare – where artificial intelligence becomes a scalable software imaging platform capable of detecting, diagnosing, and managing disease on a global scale,” — John R. Luna, Chief Executive Officer.

“I am excited to welcome John R. Luna as Light AI's new Chief Executive Officer… positioning Light AI for successful regulatory authorization and early‑stage commercialization,” — Steven Semmelmayer, Chair of the Board.